Retrieve available abstracts of 15 articles: HTML format
Single Articles
August 2025
AITHAL GP From Long to Snappy and Short Regimens for Paracetamol Overdose: Reinventing the
N-Acetyl Cysteine Wheel.
J Hepatol. 2025 Aug 11:S0168-8278(25)02403-1. doi: 10.1016/j.jhep.2025. PubMed
June 2025
INDIA-ALDANA S, Midya V, Betanzos-Robledo L, Yao M, et al Impact of metabolism-disrupting chemicals and folic acid supplementation on liver
injury and steatosis in mother-child pairs.
J Hepatol. 2025;82:956-966. PubMedAbstract available
May 2025
ISBISTER G, Chiew A, Buckley N, Harris K, et al A non-inferiority randomised controlled trial of a Shorter Acetylcysteine Regimen
for Paracetamol Overdose - the SARPO trial.
J Hepatol. 2025 May 23:S0168-8278(25)02206-8. doi: 10.1016/j.jhep.2025. PubMedAbstract available
October 2024
SEGOVIA-ZAFRA A, Villanueva-Paz M, Serras AS, Matilla-Cabello G, et al Control compounds for preclinical drug-induced liver injury assessment:
Consensus-driven systematic review by the ProEuroDILI network.
J Hepatol. 2024;81:630-640. PubMedAbstract available
September 2024
MYOTERI D, Grypari IM, Schina M, Lohse A, et al An overweight female with a history of allergies and drug-induced liver injury.
J Hepatol. 2024;81:e93-e95. PubMed
March 2024
BJORNSSON ES, Lucena MI, Andrade RJ Reply to the Letter to the Editor: Distinction of Autoimmune Hepatitis from Drug
Induced Autoimmune Like Hepatitis: The Answer Lies at the Interface.
J Hepatol. 2024 Mar 28:S0168-8278(24)00221-6. doi: 10.1016/j.jhep.2024. PubMed
February 2024
ALKASHASH A, Zhang X, Vuppalanchi R, Lammert C, et al Distinction of Autoimmune Hepatitis from Drug Induced Autoimmune Like Hepatitis:
The Answer Lies at the Interface.
J Hepatol. 2024 Feb 1:S0168-8278(24)00100-4. doi: 10.1016/j.jhep.2024. PubMed
September 2023
UZUN S, Zinner CP, Beenen AC, Alborelli I, et al Morphologic and molecular analysis of liver injury after SARS-CoV-2 vaccination
reveals distinct characteristics.
J Hepatol. 2023;79:666-676. PubMedAbstract available
August 2023
ROMA K, Mohammed S, Sieck B, Naik K, et al Kratom-induced acute liver injury: A case study and the importance of herbal
supplement regulation.
J Hepatol. 2023;79:581-584. PubMedAbstract available
May 2023
ANDRADE RJ, Aithal GP, de Boer YS, Liberal R, et al Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis
(DI-ALH): An expert opinion meeting report.
J Hepatol. 2023 May 8:S0168-8278(23)00320-3. doi: 10.1016/j.jhep.2023. PubMedAbstract available
ZHANG CJ, Meyer SR, O'Meara MJ, Huang S, et al A human liver organoid screening platform for DILI risk prediction.
J Hepatol. 2023;78:998-1006. PubMedAbstract available
DALY AK, Bjornsson ES, Lucena MI, Andrade RJ, et al Drug-induced liver injury due to nitrofurantoin: Similar clinical features, but
different HLA risk alleles in an independent cohort.
J Hepatol. 2023;78:e165-e166. PubMed
March 2023
JAGADISAN B, Dhawan A Multidisciplinary approach and reactive immunosuppression for gene therapy
related hepatotoxicity.
J Hepatol. 2023 Mar 28:S0168-8278(23)00197-6. doi: 10.1016/j.jhep.2023. PubMed
NOGUEIRAS R, Aspichueta P Expanding the roles of the renin-angiotensin system: Drug-induced liver injury.
J Hepatol. 2023;78:457-459. PubMed
November 2022
CHEN S, Lu Z, Jia H, Yang B, et al Hepatocyte-specific Mas activation enhances lipophagy and fatty acid oxidation to
protect against acetaminophen-induced hepatotoxicity in mice.
J Hepatol. 2022 Nov 9. pii: S0168-8278(22)03285. PubMedAbstract available